Dr. Adam J. Goldrich
Claim this profileUniversity of Maryland Shore Medical Center at Easton
Studies Cancer
Studies Breast Cancer
13 reported clinical trials
29 drugs studied
Area of expertise
1Cancer
Stage III
HER2 positive
Stage IV
2Breast Cancer
Stage IV
HER2 positive
ER positive
Affiliated Hospitals
Clinical Trials Adam J. Goldrich is currently running
Chemotherapy + Bevacizumab + Atezolizumab
for Colorectal Cancer
This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab may stop or slow colorectal cancer by blocking the growth of new blood vessels necessary for tumor growth. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.
Recruiting2 awards Phase 31 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
More about Adam J. Goldrich
Clinical Trial Related4 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Adam J. Goldrich has experience with
- Pembrolizumab
- Paclitaxel
- Docetaxel
- Pemetrexed
- Fluorouracil
- Leucovorin
Breakdown of trials Adam J. Goldrich has run
Cancer
Breast Cancer
Lung Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adam J. Goldrich specialize in?
Adam J. Goldrich focuses on Cancer and Breast Cancer. In particular, much of their work with Cancer has involved Stage III patients, or patients who are HER2 positive.
Is Adam J. Goldrich currently recruiting for clinical trials?
Yes, Adam J. Goldrich is currently recruiting for 3 clinical trials in Easton Maryland. If you're interested in participating, you should apply.
Are there any treatments that Adam J. Goldrich has studied deeply?
Yes, Adam J. Goldrich has studied treatments such as Pembrolizumab, Paclitaxel, Docetaxel.
What is the best way to schedule an appointment with Adam J. Goldrich?
Apply for one of the trials that Adam J. Goldrich is conducting.
What is the office address of Adam J. Goldrich?
The office of Adam J. Goldrich is located at: University of Maryland Shore Medical Center at Easton, Easton, Maryland 21601 United States. This is the address for their practice at the University of Maryland Shore Medical Center at Easton.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.